返回 Agenda
Session Chair(s)
Mark Bach, MD, PHD
Vice President, Office of the Chief Medical Officer
Johnson & Johnson, United States
Yasuto Otsubo
Review Director, Office of New Drug II
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Clinical Data Evaluation for Drug Approval - Observations from China
Ling Su, PHD
Yeehong Business School, China
Research Fellow
Clinical Data Evaluation for Drug Approval : Korean Perspective
Mee Ryung Ahn, PHD
Ministry of Food and Drug Safety, Korea, Republic of
Director
Clinical Data Evaluation for Drug Approval in Taiwan - Focusing on BSE
Li-Li Su
Center for Drug Evaluation, Taiwan
Reviewer, Division of Pharmaceutical Sciences
PMDA’s Perspectives in Global Clinical Data Evaluation for Drug Approval
Yoshiaki Uyama, PHD, MS, RPH
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director